{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:56:46Z","timestamp":1792537006767,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare disease with limited data on outcomes after transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center retrospective cohort study, we describe the outcomes of kidney transplant patients with AAV transplanted\u00a0at our institute from February 2006 to January 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 9 patients among 1026 with a pre-transplant diagnosis of AAV; all patients had received previous treatment with cyclophosphamide. Maintenance immunosuppression after transplantation was tacrolimus-based in 89% of the patients. At the end of a mean follow-up of 132\u2009\u00b1\u200961.1\u00a0months after transplantation, only one case of extrarenal vasculitis relapse was observed. The relapse rate was 0.01 per patient per year, which is comparable to that reported in the literature. However, seven patients were diagnosed with cancer after a mean follow-up of 81.4\u00a0months after transplantation; six had skin cancer and three had renal cell carcinoma (RCC) of the native kidneys (cumulative incidence of 78%). One patient died from metastatic squamous cell carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this study, we found a noticeable decrease in disease relapse (1 relapse in the present cohort vs 7 relapses in 19 patients in the previous cohort) in kidney transplant patients with AAV compared with previous data from our group (December 1987\u2013January 2006). Conversely, we found a high incidence of post-transplant cancer. This result could be attributed to reduced immunosurveillance due to immunosuppression therapy before and after transplantation. Therefore, constant cancer early diagnosis and\u00a0prevention is mandatory during the post-transplant follow-up of AAV patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-024-01951-6","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T11:21:31Z","timestamp":1717500091000},"page":"1611-1619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Kidney transplantation in patients with ANCA-associated vasculitis is associated with a high incidence of post-transplant cancer"],"prefix":"10.1093","volume":"37","author":[{"given":"Alessandro","family":"Perna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Campise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Maria","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Regalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donata","family":"Cresseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Gandolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0153-3795","authenticated-orcid":false,"given":"Giuseppe","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"issue":"3","key":"1951_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/ctr.12084","volume":"27","author":"H Marco","year":"2013","unstructured":"Marco H, Mirapeix E, Arcos E et al (2013) Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation. Clin Transplant 27(3):338\u2013347. https:\/\/doi.org\/10.1111\/ctr.12084","journal-title":"Clin Transplant"},{"key":"1951_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1070","volume":"369","author":"RW Hunter","year":"2020","unstructured":"Hunter RW, Welsh N, Farrah TE, Gallacher PJ, Dhaun N (2020) ANCA associated vasculitis. BMJ 369:m1070. https:\/\/doi.org\/10.1136\/bmj.m1070","journal-title":"BMJ"},{"issue":"12","key":"1951_CR3","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1002\/art.40313","volume":"69","author":"A Berti","year":"2017","unstructured":"Berti A, Cornec D, Crowson CS, Specks U, Matteson EL (2017) The Epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in olmsted county, minnesota: a twenty-year US population-based study. Arthritis Rheumatol 69(12):2338\u20132350. https:\/\/doi.org\/10.1002\/art.40313","journal-title":"Arthritis Rheumatol"},{"issue":"Suppl 3","key":"1951_CR4","doi-asserted-by":"publisher","first-page":"iii42","DOI":"10.1093\/rheumatology\/keaa089","volume":"59","author":"AJ Mohammad","year":"2020","unstructured":"Mohammad AJ (2020) An update on the epidemiology of ANCA-associated vasculitis. Rheumatology (Oxford) 59(Suppl 3):iii42\u2013iii50. https:\/\/doi.org\/10.1093\/rheumatology\/keaa089","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1951_CR5","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s10157-012-0701-8","volume":"17","author":"F Ferrario","year":"2013","unstructured":"Ferrario F, Vanzati A, Pagni F (2013) Pathology of ANCA-associated vasculitis. Clin Exp Nephrol 17(5):652\u2013658. https:\/\/doi.org\/10.1007\/s10157-012-0701-8","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"1951_CR6","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1136\/annrheumdis-2018-213452","volume":"77","author":"ZS Wallace","year":"2018","unstructured":"Wallace ZS, Wallwork R, Zhang Y et al (2018) Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System. Ann Rheum Dis 77(9):1333\u20131338. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213452","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"1951_CR7","doi-asserted-by":"publisher","first-page":"i159","DOI":"10.1093\/ndt\/gfu328","volume":"30","author":"Z Hruskova","year":"2015","unstructured":"Hruskova Z, Geetha D, Tesar V (2015) Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant 30(Suppl 1):i159\u2013i163. https:\/\/doi.org\/10.1093\/ndt\/gfu328","journal-title":"Nephrol Dial Transplant"},{"key":"1951_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO (2021) Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 100:S1\u2013S276","journal-title":"Kidney Int"},{"issue":"9","key":"1951_CR9","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1111\/j.1600-6143.2007.01904.x","volume":"7","author":"G Moroni","year":"2007","unstructured":"Moroni G, Torri A, Gallelli B et al (2007) The long-term prognosis of renal transplant in patients with systemic vasculitis. Am J Transplant 7(9):2133\u20132139. https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01904.x","journal-title":"Am J Transplant"},{"issue":"6","key":"1951_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40620-019-00642-x","volume":"32","author":"MS Sagmeister","year":"2019","unstructured":"Sagmeister MS, Grigorescu M, Sch\u00f6nermarck U (2019) Kidney transplantation in ANCA-associated vasculitis. J Nephrol 32(6):919\u2013926. https:\/\/doi.org\/10.1007\/s40620-019-00642-x","journal-title":"J Nephrol"},{"issue":"1","key":"1951_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","volume":"75","author":"D Geetha","year":"2020","unstructured":"Geetha D, Jefferson JA (2020) ANCA-associated vasculitis: core curriculum 2020. Am J Kidney Dis 75(1):124\u2013137. https:\/\/doi.org\/10.1053\/j.ajkd.2019.04.031","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1951_CR12","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s10067-020-05055-x","volume":"39","author":"Z Thet","year":"2020","unstructured":"Thet Z, Lam AK, Ranganathan D et al (2020) Cancer risks along the disease trajectory in antineutrophil cytoplasmic antibody associated vasculitis. Clin Rheumatol 39(9):2501\u20132513. https:\/\/doi.org\/10.1007\/s10067-020-05055-x","journal-title":"Clin Rheumatol"},{"key":"1951_CR13","doi-asserted-by":"publisher","first-page":"6013038","DOI":"10.1155\/2017\/6013038","volume":"2017","author":"S Sriskandarajah","year":"2017","unstructured":"Sriskandarajah S, Bostad L, Myklebust T\u00c5 et al (2017) Cancer in ANCA-associated glomerulonephritis: a registry-based cohort study. Int J Nephrol 2017:6013038. https:\/\/doi.org\/10.1155\/2017\/6013038","journal-title":"Int J Nephrol"},{"issue":"10","key":"1951_CR14","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1097\/01.TP.0000083897.44391.E8","volume":"76","author":"P Pedotti","year":"2003","unstructured":"Pedotti P, Cardillo M, Rossini G et al (2003) Incidence of cancer after kidney transplant: results from the North Italy transplant program. Transplantation 76(10):1448\u20131451. https:\/\/doi.org\/10.1097\/01.TP.0000083897.44391.E8","journal-title":"Transplantation"},{"issue":"2","key":"1951_CR15","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/ajt.16825","volume":"22","author":"M Taborelli","year":"2022","unstructured":"Taborelli M, Serraino D, Cimaglia C et al (2022) The impact of cancer on the risk of death with a functioning graft of Italian kidney transplant recipients. Am J Transplant 22(2):588\u2013598. https:\/\/doi.org\/10.1111\/ajt.16825","journal-title":"Am J Transplant"},{"issue":"8","key":"1951_CR16","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2165\/00003495-200767080-00006","volume":"67","author":"A Gutierrez-Dalmau","year":"2007","unstructured":"Gutierrez-Dalmau A, Campistol JM (2007) Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 67(8):1167\u20131198. https:\/\/doi.org\/10.2165\/00003495-200767080-00006","journal-title":"Drugs"},{"issue":"1","key":"1951_CR17","first-page":"100","volume":"35","author":"M Faurschou","year":"2008","unstructured":"Faurschou M, Sorensen IJ, Mellemkjaer L et al (2008) Malignancies in Wegener\u2019s granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol 35(1):100\u2013105","journal-title":"J Rheumatol"},{"issue":"10","key":"1951_CR18","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1136\/ard.2003.019125","volume":"63","author":"A Knight","year":"2004","unstructured":"Knight A, Askling J, Granath F, Sparen P, Ekbom A (2004) Urinary bladder cancer in Wegener\u2019s granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis 63(10):1307\u20131311. https:\/\/doi.org\/10.1136\/ard.2003.019125","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1951_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363(3):221\u2013232. https:\/\/doi.org\/10.1056\/NEJMoa0909905","journal-title":"N Engl J Med"},{"issue":"3","key":"1951_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363(3):211\u2013220. https:\/\/doi.org\/10.1056\/NEJMoa0909169","journal-title":"N Engl J Med"},{"issue":"6","key":"1951_CR21","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/annrheumdis-2014-206404","volume":"74","author":"RB Jones","year":"2015","unstructured":"Jones RB, Furuta S, Tervaert JW et al (2015) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Ann Rheum Dis 74(6):1178\u20131182. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206404","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1951_CR22","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/annrheumdis-2016-209925","volume":"76","author":"EE van Daalen","year":"2017","unstructured":"van Daalen EE, Rizzo R, Kronbichler A et al (2017) Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis. Ann Rheum Dis 76(6):1064\u20131069. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209925","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1951_CR23","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/14712598.2020.1748597","volume":"20","author":"L Raffray","year":"2020","unstructured":"Raffray L, Guillevin L (2020) Rituximab treatment of ANCA-associated vasculitis. Expert Opin Biol Ther 20(8):899\u2013910. https:\/\/doi.org\/10.1080\/14712598.2020.1748597","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"1951_CR24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1097\/TP.0000000000000910","volume":"100","author":"A G\u00f6\u00e7ero\u011flu","year":"2016","unstructured":"G\u00f6\u00e7ero\u011flu A, Rahmattulla C, Berden AE et al (2016) The Dutch Transplantation in Vasculitis (DUTRAVAS) study: outcome of renal transplantation in antineutrophil cytoplasmic antibody-associated glomerulonephritis. Transplantation 100(4):916\u2013924. https:\/\/doi.org\/10.1097\/TP.0000000000000910","journal-title":"Transplantation"},{"issue":"2","key":"1951_CR25","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ucl.2021.12.010","volume":"49","author":"O Aiyegbusi","year":"2022","unstructured":"Aiyegbusi O, McGregor E, McManus SK, Stevens KI (2022) Immunosuppression therapy in kidney transplantation. Urol Clin North Am 49(2):345\u2013360. https:\/\/doi.org\/10.1016\/j.ucl.2021.12.010","journal-title":"Urol Clin North Am"},{"issue":"6","key":"1951_CR26","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/rheumatology\/keaa699","volume":"60","author":"J Rathmann","year":"2021","unstructured":"Rathmann J, Jayne D, Segelmark M et al (2021) Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study. Rheumatology (Oxford) 60(6):2745\u20132754. https:\/\/doi.org\/10.1093\/rheumatology\/keaa699","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01951-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-024-01951-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-024-01951-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:54:00Z","timestamp":1777564440000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/6\/1611\/8306792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["1951"],"URL":"https:\/\/doi.org\/10.1007\/s40620-024-01951-6","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"19 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial or non-financial interests or personal relationships that could directly affect the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and the Declaration of Istanbul and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Informed consent was obtained from all the individuals included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}